Organic Letters
Letter
See: (a) Bedford, R. B.; Bowen, J. G.; Davidson, R. B.; Haddow, M. F.;
Seymour-Julen, A. E.; Sparkes, H. A.; Webster, R. L. Angew. Chem., Int.
Ed. 2015, 54, 6591−6594. (b) Mekareeya, A.; Walker, P. R.; Couce-Rios,
A.; Campbell, C. D.; Steven, A.; Paton, R. S.; Anderson, E. A. J. Am.
Chem. Soc. 2017, 139, 10104−10114.
Discovery, Informatics, and Structural Life Science) from the
Ministry of Education, Culture, Sports, Science, and Technology,
Japan (MEXT), JST ACT-C Grant Number JPMJCR12YM,
Japan.
(27) Mori, M.; Kozawa, Y.; Nishida, M.; Kanamaru, M.; Onozuka, K.;
Takimoto, M. Org. Lett. 2000, 2, 3245−3247.
REFERENCES
■
(28) (a) Arisawa, M.; Terada, Y.; Nakagawa, M.; Nishida, A. Angew.
Chem., Int. Ed. 2002, 41, 4732−4734. (b) Terada, Y.; Arisawa, M.;
Nishida, A. Angew. Chem., Int. Ed. 2004, 43, 4063−4067. (c) Arisawa,
M.; Terada, Y.; Takahashi, K.; Nakagawa, M.; Nishida, A. J. Org. Chem.
2006, 71, 4255−4261. (d) Ohno, S.; Takamoto, K.; Fujioka, H.;
Arisawa, M. Org. Lett. 2017, 19, 2422−2425. (e) Takamoto, K.; Ohno,
S.; Hyogo, N.; Fujioka, H.; Arisawa, M. J. Org. Chem. 2017, 82, 8733−
8742.
(1) Hiyama, T. In Organometallics in Synthesis: Third Manual;
Schlosser, M., Ed.; Wiley-VCH: Weinheim, 2013; pp 373−544.
(2) For selected recent reviews on the silacyclic compounds, see:
(a) Shainyan, B. A.; Kleinpeter, E. Tetrahedron 2013, 69, 5927−5936.
(b) Cusak, A. Chem. - Eur. J. 2012, 18, 5800−5824.
(3) For a review on organosilicon molecules with medicinal
applications, see: Franz, A. K.; Wilson, S. O. J. Med. Chem. 2013, 56,
388−405.
(29) (a) Nieto-Oberhuber, C.; Munoz, M. P.; Lop
́
ez, S.; Jimen
ez, E.; Raducan, M.; Echavarren,
A. M. Chem. - Eur. J. 2006, 12, 1677−1693. (b) Genin, E.; Leseurre, L.;
Toullec, P. Y.; Genet
́
ez-
̃
(4) Barcza, S.; Hoffman, C. W. Tetrahedron 1975, 31, 2363−2367.
(5) (a) Geyer, M.; Karlsson, O.; Baus, J. A.; Wellner, E.; Tacke, R. J.
Org. Chem. 2015, 80, 5804−5811. (b) Jachak, G.; Ramesh, R.; Sant, D.
G.; Jorwekar, S. U.; Jadhav, M. R.; Tupe, S. G.; Deshpande, M. V.;
Reddy, D. S. ACS Med. Chem. Lett. 2015, 6, 1111−1116.
(6) Shimizu, M.; Hiyama, T. Synlett 2012, 23, 973−989.
(7) Liu, J.; Yue, Z.; Wu, F.; Jian, M.; Guobi, C.; Peng, L.; Zhan, Q.;
Yongli, Z.; Jianxun, Z.; Kraft, P. Eur. J. Org. Chem. 2016, 2016, 976−982.
(8) Corey, J. Y.; Dueber, M.; Bichlmeir, B. J. Organomet. Chem. 1971,
26, 167−173.
Nunez, E.; Nevado, C.; Herrero-Gom
́
́
̃
̂
, J.-P.; Michelet, V. Synlett 2007, 11, 1780−1784.
(30) Faller, J. W.; Fontaine, P. P. J. Organomet. Chem. 2006, 691, 1912−
1918.
(31) (a) Galland, J.-C.; Savignac, M.; Genet
1997, 38, 8695−8698. (b) Charruault, L.; Michelet, V.; Genet
Tetrahedron Lett. 2002, 43, 4757−4760. (c) Nevado, C.; Charruault, L.;
Michelet, V.; Nieto-Oberhuber, C.; Munoz, M. P.; Mendez, M.; Rager,
, J.-P.; Echavarren, A. M. Eur. J. Org. Chem. 2003, 2003,
̂
, J.-P. Tetrahedron Lett.
̂
, J.-P.
́
̃
M.-N.; Genet
706−713.
(32) (a) Men
Soc. 2000, 122, 11549−11550. (b) Men
C.; Cardenas, D. J.; Echavarren, A. M. J. Am. Chem. Soc. 2001, 123,
10511−10520. (c) Charruault, L.; Michelet, V.; Taras, R.; Gladiali, S.;
Genet
̂
(9) Shiratori, S.; Yasuike, S.; Kurita, J.; Tsuchiya, T. Chem. Pharm. Bull.
1994, 42, 2441−2448.
(10) Ding, B.; Teng, Z.; Keese, R. J. Org. Chem. 2002, 67, 8906−8910.
(11) Leigh, W. J.; Li, X. J. Am. Chem. Soc. 2003, 125, 8096−8097.
(12) Ahmad, I.; Falck-Pedersen, M. L.; Undheim, K. J. Organomet.
Chem. 2001, 625, 160−172.
(13) Sudo, T.; Asao, N.; Yamamoto, Y. J. Org. Chem. 2000, 65, 8919−
8923.
(14) Horino reported a Au-catalyzed hydroxycyclization to give a
seven-membered silacycle, but it was only one example, and the
compound data was not given. Horino, Y.; Nakashima, Y.; Hashimoto,
K.; Kuroda, S. Synlett 2010, 19, 2879−2882.
́
dez, M.; Munoz, M. P.; Echavarren, A. M. J. Am. Chem.
̃
́
dez, M.; Munoz, M. P.; Nevado,
̃
̀
̂
, J.-P. Chem. Commun. 2004, 850−851.
(33) Levine, M. N.; Raines, R. T. Chem. Sci. 2012, 3, 2412−2420.
(34) Tsukamoto, H.; Ueno, T.; Kondo, Y. J. Am. Chem. Soc. 2006, 128,
1406−1407.
(35) An alternative route is a concerted process. Because 2 is obtained
by a 6-exo-trig cyclization, 3 can be obtained by a 7-endo-trig cyclization.
Both cyclizations are acceptable in the Baldwin’s rule.
(15) Hino, K.; Matsumoto. Prog. Med. Chem. 1990, 27, 123−141.
(16) For selected recent reviews of the transition-metal-catalyzed
cycloisomerization, see: (a) Fang, G.; Bi, X. Chem. Soc. Rev. 2015, 44,
8124−8173. (b) Neff, R. K.; Frantz, D. E. Tetrahedron 2015, 71, 7−18.
(c) Furstner, A. Acc. Chem. Res. 2014, 47, 925−938.
̈
(17) (a) Huang, C.; Kothandaraman, P.; Koh, B. Q.; Chan, P. W. H.
Org. Biomol. Chem. 2012, 10, 9067−9078. (b) Boyer, F.-D.; Le Goff, X.;
Hanna, I. J. Org. Chem. 2008, 73, 5163−5166.
(18) Lee, Y.-J.; Schrock, R. R.; Hoveyda, A. H. J. Am. Chem. Soc. 2009,
131, 10652−10661.
(19) Trost, B. M.; Toste, F. D. J. Am. Chem. Soc. 2002, 124, 5025−
5036.
(20) Ferrer, C.; Raducan, M.; Nevado, C.; Claverie, C. K.; Echavarren,
A. M. Tetrahedron 2007, 63, 6306−6316.
(21) Inagaki, F.; Matsumoto, C.; Okada, Y.; Maruyama, N.; Mukai, C.
Angew. Chem., Int. Ed. 2015, 54, 818−822.
(22) (a) Makino, T.; Itoh, K. Tetrahedron Lett. 2003, 44, 6335−6338.
(b) Lu, P.; Ma, S. Org. Lett. 2007, 9, 2095−2097.
(23) Cabello, N.; Rodríguez, C.; Echavarren, A. M. Synlett 2007, 11,
1753−1758.
(24) Nishizawa, M.; Yadav, V. K.; Skwarczynski, V. K.; Takao, H.;
Imagawa, H.; Sugihara, T. Org. Lett. 2003, 5, 1609−1611.
(25) (a) There is a possibility that the Pd species forms a dinuclear
complex, but the mononuclear species has different activity and
selectivity from the dinuclear complex. In general, both Pd2(dba)3 and
Pd(dba)2 are believed to be equivalent Pd(0) species. (b) The purity of
the commercially available Pd2(dba)3 complexes is reported in the range
64−92%. See: Zalesskiy, S. S.; Ananikov, V. P. Organometallics 2012, 31,
2302−2309.
(26) When water exists in the solvent, the palladium complex may form
new aggregates. For example, [Pd3(μ2-OH)(OAc)5] is known. It is also
known that these aggregates may affect the cycloisomerization reaction.
D
Org. Lett. XXXX, XXX, XXX−XXX